Results 21 to 30 of about 14,613 (227)

A pilot study on the acute conversion and maintenance of sinus rhythm in rheumatic atrial fibrillation using oral flecainide

Indian Heart Journal, 2020
Background: Achievement of sinus rhythm (SR) is an important goal in rheumatic atrial fibrillation (AF). Studies in rheumatic AF have often used amiodarone for rhythm control.
Anindya Ghosh, Aditya Kapoor, Roopali Khanna, Ankit Sahu, Sudeep Kumar, Naveen Garg, Satyendra Tewari, Pravin Goel   +7 more
doaj   +2 more sources

Cardiogenic Shock in a Hemodialyzed Patient on Flecainide: Treatment with Intravenous Fat Emulsion, Extracorporeal Cardiac Life Support, and CytoSorb® Hemoadsorption

Case Reports in Cardiology, 2019
A 67-year-old woman with a history of end-stage renal disease on hemodialysis received a therapeutic dose (150 mg daily) of flecainide for three weeks.
Nicolas De Schryver, Philippe Hantson, Vincent Haufroid, Mélanie Dechamps   +3 more
doaj   +2 more sources

Long-Term Serial Exercise Stress Testing in Catecholaminergic Polymorphic Ventricular Tachycardia on Beta-Blocker and Flecainide Therapy. [PDF]

J Cardiovasc Electrophysiol
ABSTRACT Introduction Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a potentially life‐threatening arrhythmic disorder typically treated with beta‐blockers and, occasionally, with flecainide. Methods All patients underwent genetic testing, electrocardiogram, echocardiogram, and exercise testing.
Wangüemert-Perez F, Ostos-Cañero G, Wangüemert-Guerra M, Acosta-Materan C, Cárdenes-León A, Caballero-Dorta E, Pérez-Rodríguez K, Brugada R, Brugada J, Martínez-Quintana E.   +9 more
europepmc   +2 more sources

Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

Circulation, 2023
BACKGROUND: In severely affected patients with catecholaminergic polymorphic ventricular tachycardia, beta-blockers are often insufficiently protective. The purpose of this study was to evaluate whether flecainide is associated with a lower incidence of ...
A. Bergeman, K. Lieve, Dania Kallas, J. Bos, Ferran Rosés I. Noguer, I. Denjoy, E. Zorio, Janneke A. E. Kammeraad, Puck J. Peltenburg, Katie Tobert, T. Aiba, Joseph Atallah, F. Drago, Anjan S. Batra, Ramon Brugada, M. Borggrefe, S. Clur, M. Cox, Andrew Davis, S. Dhillon, S. Etheridge, Peter Fischbach, Sonia Franciosi, K. Haugaa, Minoru Horie, C. Johnsrude, A. Kane, Ulrich Krause, S. Kwok, M. LaPage, S. Ohno, V. Probst, Jason D. Roberts, T. Robyns, F. Sacher, C. Semsarian, Jonathan R. Skinner, H. Swan, T. Tavacova, Svjetlana Tisma-Dupanovic, J. Tfelt-Hansen, S. Yap, Prince J. Kannankeril, A. Leenhardt, J. Till, Shubhayan Sanatani, Michael W. T. Tanck, M. Ackerman, A. Wilde, C. van der Werf   +49 more
semanticscholar   +1 more source

The Feasibility and Safety of Flecainide Use Among Patients With Varying Degrees of Coronary Disease.

JACC Clinical Electrophysiology, 2023
BACKGROUND Class 1C antiarrhythmic agents are effective for treating atrial tachyarrhythmias, but their use is restricted in patients with coronary artery disease (CAD).
S. Kiani, Michael N. Sayegh, R. Ibrahim, N. Bhatia, Faisal M. Merchant, Anand D. Shah, Stacy B. Westerman, D. D. De Lurgio, Anshul M. Patel, Christine M. Thompkins, A. León, M. Lloyd, M. El-Chami   +12 more
semanticscholar   +1 more source

Rationale and Design of a Randomized Controlled Clinical Trial on the Safety and Efficacy of Flecainide versus Amiodarone in the Cardioversion of Atrial Fibrillation at the Emergency Department in Patients with Coronary Artery Disease (FLECA-ED)

Journal of Clinical Medicine, 2023
Pharmacologic cardioversion is a well-established alternative to electric cardioversion for hemodynamically stable patients, as it skips the risks associated with anesthesia.
P. Tsioufis, D. Tsiachris, I. Doundoulakis, A. Kordalis, C. Antoniou, P. Vlachakis, P. Theofilis, E. Manta, K. Gatzoulis, J. Parissis, K. Tsioufis   +10 more
semanticscholar   +1 more source

Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone. [PDF]

Diabetes Obes Metab
ABSTRACT Aims To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide, sotalol, or propafenone) while receiving sulfonylurea. Materials and Methods We conducted a population‐based cohort study using South
Bea S, Lee H, Cho YM, Choi YJ, Shin JY, Bykov K.   +5 more
europepmc   +2 more sources

Increased atrial effectiveness of flecainide conferred by altered biophysical properties of sodium channels

Journal of Molecular and Cellular Cardiology, 2022
Atrial fibrillation (AF) affects over 1% of the population and is a leading cause of stroke and heart failure in the elderly. A feared side effect of sodium channel blocker therapy, ventricular pro-arrhythmia, appears to be relatively rare in patients ...
Sian O' Brien, Andrew P. Holmes, Daniel M. Johnson, S. Kabir, Christopher O' Shea, M. O'Reilly, Adelisa Avezzu, J. Reyat, A. Hall, Clara Apicella, P. Ellinor, Steven Niederer, N. Tucker, L. Fabritz, P. Kirchhof, D. Pavlovic   +15 more
semanticscholar   +1 more source

Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm

Circulation: Arrhythmia and Electrophysiology, 2022
Background: Oral and intravenous flecainide is recommended for cardioversion of atrial fibrillation. In this open-label, dose-escalation study, the feasibility of delivering flecainide via oral inhalation (flecainide acetate inhalation solution) for ...
H. Crijns, A. Elvan, N. Al-Windy, Y. Tuininga, E. Badings, I. Aksoy, I. V. van Gelder, P. Madhavapeddi, A. Camm, P. Kowey, J. Ruskin, L. Belardinelli   +11 more
semanticscholar   +1 more source

Flecainide intoxication in pediatric patients with supraventricular tachycardia

Annals of Pediatric Cardiology, 2020
Flecainide is a class IC antiarrhythmic indicated for ventricular and supraventricular arrhythmias in pediatric patients without structural heart disease.
Guiem Vaquer, Laura Marfil, Josep Ortega, Anna Sabate-Rotes, Ferran Gran-Ipina, Ferran Roses-Noguer   +5 more
doaj   +1 more source